UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | P | R | S | T | V | W | Y
Number of items: 60.

A

Ang, JE; Olmos, D; Moreno-Garcia, V; Brunetto, A; Papadatos-Pastos, D; Arkenau, HT; Blanco, M; ... Kaye, SB; + view all (2011) Utility of novel dynamic clinical indices in patients (pts) enrolled in a phase I (Ph I) oncology trial as markers of prognosis and treatment benefit. Journal of Clinical Oncology , 29 (Suppl 1)

Arkenau, H-K; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? ANNALS OF ONCOLOGY , 22 (1) 239-U282. 10.1093/annonc/mdq676.

B

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; Sjoholm, R; ... Lee, M; + view all (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, H-T; Graeven, U; ... Reinacher-Schick, A; + view all (2011) Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group. CLINICAL COLORECTAL CANCER , 10 (1) pp. 24-29. 10.3816/CCC.2011.n.003.

Bridgewater, JA; Stubbs, C; Primrose, JN; National Cancer Research Institute (UK) Upper Gastrointestinal S, ; (2011) BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer. J Clin Oncol , 29 (15_suppl) 4125-.

Brunetto, A; Olmos, D; Arkenau, H-T; Tan, D; Yap, T; de Bono, J; Barriuso, J; (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401-. 10.1155/2011/861401.

C

Calvert, AH; (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Calvert, AH; Jackson, JC; Hutton, C; Swart, AM; Qian, W; Kwakye, C; Fossati, R; ... Lunec, J; + view all (2011) Evaluation of p53 mutation as a predictive biomarker for outcome to chemotherapy in ovarian cancer. J Clin Oncol , 29 (15_suppl) 10522-.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; ... Lee, M; + view all (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) pp. 366-371. 10.1016/j.ymeth.2010.12.022.

D

Dedes, KJ; Wilkerson, PM; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, JS; (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. CELL CYCLE , 10 (8) pp. 1192-1199. 10.4161/cc.10.8.15273.

E

El-Khouly, F; Khan, MS; Toumpanakis, C; Meyer, T; Caplin, M; (2011) Challenges in the Management of VIPoma Patients. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. pp. 3-4). KARGER

Ertemi, H; Mumtaz, FH; Howie, AJ; Mikhailidis, DP; Thompson, CS; (2011) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation. J UROLOGY , 185 (6) 2414 - 2420. 10.1016/j.juro.2011.02.2645.

Esfandiari, A; Shoaib, M; Hogarth, L; Panlilio, L; (2011) ESTABLISHING PAVLOVIAN TO INSTRUMENTAL TRANSFER (PIT) WITH INTRAVENOUS NICOTINE AND SUCROSE IN RATS. In: (Proceedings) Summer Meeting of the British-Association-for-Psychopharmacology. (pp. A44-A44). SAGE PUBLICATIONS LTD

F

Forster, MD; Dedes, K; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C; ... Molife, LR; + view all (2011) Treatment with the PARP inhibitor olaparib in a patient with PTEN-deficient endometrial cancer. Nature Reviews Clinical Oncology , 8 (5) pp. 302-306.

Fruhwirth, GO; Fernandes, LP; Weitsman, G; Patel, G; Kelleher, M; Lawler, K; Brock, A; ... Ng, T; + view all (2011) How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology. Chemphyschem , 12 (3) pp. 442-461. 10.1002/cphc.201000866.

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , 80 (1) pp. 31-39. 10.1016/j.critrevonc.2010.10.009.

G

Guppy, A; Jamal-Hanjani, M; Pickering, L; (2011) Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. FUTURE ONCOLOGY , 7 (6) pp. 727-736. 10.2217/FON.11.49.

H

Hochdoerfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; Krystal, G; (2011) Activation of the PI3K pathway increases TLR-induced TNF-alpha and IL-6 but reduces IL-1 beta production in mast cells. CELLULAR SIGNALLING , 23 (5) pp. 866-875. 10.1016/j.cellsig.2011.01.012.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) pp. 1197-1205. 10.1007/s00467-010-1701-0.

J

Jamal-Hanjani, M; Pettengell, R; (2011) Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY , 7 (11) pp. 1441-1448. 10.1517/17425255.2011.618834.

Johansson, ÅM; Hill, N; Perisoglou, M; Whelan, J; Karlsson, MO; Standing, JF; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Ther Drug Monit , 33 (6) pp. 711-718. 10.1097/FTD.0b013e31823615e1.

Jose Garcia-Gomez, J; Babiano, R; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Nop6, a component of 90S pre-ribosomal particles, is required for 40S ribosomal subunit biogenesis in Saccharomyces cerevisiae. RNA BIOLOGY , 8 (1) pp. 112-124. 10.4161/rna.8.1.14143.

K

Khan, MS; El-Khouly, F; Toumpanakis, C; Meyer, T; Caplin, M; Luong, T; (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Caplin, M; Meyer, T; (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Kristeleit, RS; baird, R; venugopal, B; wilkins, D; maccormick, F; granata, R; crawford, D; ... de bono, J; + view all (2011) Cardiac effects in a first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD) phase I trial of JNJ-26481585, a second-generation oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with refractory cancer. Molecular Cancer Therapeutics , 10 (11)

Krug, LM; Kindler, H; Calvert, H; Manegold, C; Tsao, AS; Fennell, D; Lubiniecki, GM; ... Baas, P; + view all (2011) VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase iii, Randomized, Double-Blind, Placebo-Controlled Trial. EUROPEAN JOURNAL OF CANCER , 47 pp. 2-3. 10.1016/S0959-8049(11)70098-3.

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; Keppler, M; ... Lawrence, MJ; + view all (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; Hart, SL; ... Lawrence, MJ; + view all (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

L

Lemech, C; Arkenau, HT; (2011) Biomarkers in advanced colorectal cancer: Challenges in translating clinical research into practice. Cancers , 3 (2) pp. 1844-1860. 10.3390/cancers3021844. Gold open access

Lemech, CR; Kristeleit, RS; Arkenau, H; (2011) Novel Oncology drug development strategies in the era of personalised medicine. In: Drug Discovery and Development. InTech

Lemech, CR; Kristeleit, RS; Arkenau, HT; (2011) Novel Oncology Drug Development Strategies in the Era of Personalised Medicine. In: Kapetanovic, IM, (ed.) Drug Discovery and Development - Present and Future.

Liccardi, G.; (2011) Nuclear EGFR modulation of DNA repair. Doctoral thesis , UCL (University College London). Green open access
file

Lin, S; Kiakos, K; Lee, M; Hochhauser, D; Hartley, JA; (2011) Targeting the Mlul cell cycle box (MCB) sequence 5 '-ACGCGT-3 ' in the human Dbf4 promoter using the rationally designed polyamide formamido-imidazole-pyrrole-imidazole (f-IPI). CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-665.

Liu, H; Wang, W; Chew, S-K; Lee, S-C; Li, J; Vassiliou, GS; Green, T; ... Liu, P; + view all (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) pp. 689-695. 10.1002/dvg.20741.

Loizou, JI; Sancho, R; Kanu, N; Bolland, DJ; Yang, F; Rada, C; Corcoran, AE; (2011) ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma. Cancer Cell , 19 (5) pp. 587-600. 10.1016/j.ccr.2011.03.022.

Lowe, H.L.; (2011) Design, construction and evaluation of a humanised ADEPT system. Doctoral thesis , UCL (University College London).

M

Mansur, A; Little, MA; Oh, WC; Jacques, S; Nightingale, P; Howie, AJ; Savage, COS; (2011) Immune Profile and Epstein-Barr Virus Infection in Acute Interstitial Nephritis: An Immunohistochemical Study in 78 Patients. NEPHRON CLINICAL PRACTICE , 119 (4) C293-C300. 10.1159/000329671.

McCaughan, F; Pipinikas, CP; Janes, SM; George, PJ; Rabbitts, PH; Dear, PH; (2011) Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia. J PATHOL , 224 (2) 153 - 159. 10.1002/path.2887.

Melichar, B; Casado, E; Bridgewater, J; Bennouna, J; Campone, M; Vitek, P; Delord, J-P; ... Tabernero, J; + view all (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. BRITISH JOURNAL OF CANCER , 105 (11) pp. 1646-1653. 10.1038/bjc.2011.438.

Middleton, GW; Gwyther, SJ; Brown, SR; Maughan, T; Olivier, C; Richman, S; Maisey, NR; ... UK NCRI Colorectal Clinical Studies Group, ; + view all (2011) Biomodulation of irinotecan using ciclosporin: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). J Clin Oncol , 29 (15_suppl) 3566-.

P

Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; Arkenau, H-T; ... Judson, I; + view all (2011) A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors. CLINICAL CANCER RESEARCH , 17 (6) pp. 1561-1570. 10.1158/1078-0432.CCR-10-1927.

Patel, GS; Kiuchi, T; Lawler, K; Ofo, E; Fruhwirth, GO; Kelleher, M; Shamil, E; ... Ng, T; + view all (2011) The challenges of integrating molecular imaging into the optimization of cancer therapy. Integr Biol (Camb) , 3 (6) pp. 603-631. 10.1039/c0ib00131g.

R

Rowley, MI; Barber, PR; Coolen, ACC; Vojnovic, B; (2011) Bayesian analysis of fluorescence lifetime imaging data. Progress in Biomedical Optics and Imaging - Proceedings of SPIE , 7903 10.1117/12.873890.

Rustin, G; Reed, N; Jayson, GC; Ledermann, JA; Adams, M; Perren, T; Poole, C; ... Kaye, S; + view all (2011) A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (11) 2411 - 2416. 10.1093/annonc/mdq780.

S

Salazar, R; Plummer, R; Oaknin, A; Robinson, A; Pardo, B; Soto-Matos, A; Yovine, A; ... Calvert, AH; + view all (2011) Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas. INVEST NEW DRUG , 29 (6) 1406 - 1413. 10.1007/s10637-010-9488-1.

Saravanan, K; Barlow, HC; Barton, M; Calvert, AH; Golding, BT; Newell, DR; Northen, JS; ... Griffin, RJ; + view all (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Siddiqui, GK; Maclean, AB; Elmasry, K; Fong, AWT; Morris, RW; Rashid, M; Begent, RHJ; (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. ANGIOGENESIS , 14 (2) 155 - 161. 10.1007/s10456-010-9199-4.

Sivabalasingham, S; Fersht, N; D'Souza, D; Rosenberg, I; Stacey, C; Davies, P; Guerro-Urbano, T; (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Smith, SW; Eardley, KS; Croft, AP; Nwosu, J; Howie, AJ; Cockwell, P; Isacke, CM; ... Savage, COS; + view all (2011) CD248(+) stromal cells are associated with progressive chronic kidney disease. KIDNEY INTERNATIONAL , 80 (2) pp. 200-208. 10.1038/ki.2011.103.

T

Thirlwell, C; Schulz, L; Eymard, M; Luong, T; Meyer, T; Davidson, B; Teschendorff, A; ... Beck, S; + view all (2011) Integrated Genome-Wide DNA Methylation and mRNA Expression Analysis of Pancreatic NETs Identifies Differential Activation of the Hypoxia Inducible Factor (HIF) Pathway between Low and Intermediate Grade Tumors. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. pp. 12-13). KARGER

Thirlwell, C; Schulz, LKE; Dibra, HK; Beck, S; (2011) Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy. CLINICAL EPIGENETICS , 3 (ARTN 9) 10.1186/1868-7083-3-9.

V

Vazquez, I; Bridgewater, J; (2011) Nonsurgical therapy of biliary tract cancer. CURRENT OPINION IN GASTROENTEROLOGY , 27 (3) pp. 258-261. 10.1097/MOG.0b013e3283454f09.

W

Wang, XD; Lapi, E; Sullivan, A; Ratnayaka, I; Goldin, R; Hay, R; Lu, X; (2011) SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence. Cell Death Differ , 18 (2) pp. 304-314. 10.1038/cdd.2010.101.

Westbury, CB; Sahlberg, KK; Borresen-Dale, AL; Isacke, CM; Yarnold, JR; (2011) Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. RADIAT ONCOL , 6 , Article 42. 10.1186/1748-717X-6-42. Gold open access

Whelan, JS; Gelderblom, AH; Jinks, R; Sydes, M; Bramwell, VH; van Glabbeke, M; Grimer, RJ; ... Taminiau, AHM; + view all (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup randomised controlled trials. Eur J Cancer (47) pp. 895-902.

Whelan, JS; Jinks, RC; McTiernan, A; Sydes, MR; Hook, JM; Trani, L; Uscinska, B; ... Gelderblom, H; + view all (2011) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 10.1093/annonc/mdr491.

Whelan, JS; Miller, R; (2011) Lung carcinoma with hypertropic osteoarthropathy in a teenager. Rare Tumours , 3:e8

Wykosky, J; Fenton, T; Furnari, F; Cavenee, WK; (2011) Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chin J Cancer , 30 (1) pp. 5-12. Gold open access

Y

Young, RJ; Tin, A; Brown, NJ; Staton, C; Lee, SM; Jital, M; Woll, P; (2011) SERUM BIOMARKERS IN LUNG CANCER PATIENTS FROM TWO CLINICAL TRIALS OF CHEMOTHERAPY WITH OR WITHOUT THALIDOMIDE. JOURNAL OF THORACIC ONCOLOGY , 6 (6) S1058-S1059.

This list was generated on Sun Apr 15 01:55:02 2018 BST.